SciVision Biotech Inc. announced that Cross-linked hyaluronic acid synovial fluid supplement ?HYAJOINT Plus?, developed and produced by the company, has obtained the medical device license (ALVARA N?197). This product contains cross-linked hyaluronic acid, which can increase joint lubrication and reduce joint friction. For the patients with osteoarthritis, it can restrain the degeneration of cartilage, enhance its metabolism, relieve pain and discomfort, improve daily activities and increase range of activities of joints.

The company has obtained the Macao medical device license, which can increase the sales performance in the Macao market and contribute to the company's revenue.